Holen Sie sich die Stockscreener-App
7.98
3.51%
0.28
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.70
Offen:
$7.78
24-Stunden-Volumen:
2.20M
Relative Volume:
0.44
Marktkapitalisierung:
$1.30B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$440.30M
KGV:
3.3522
EPS:
2.3805
Netto-Cashflow:
$-251.02M
1W Leistung:
-1.48%
1M Leistung:
-20.14%
6M Leistung:
-12.22%
1J Leistung:
+27.72%
1-Tages-Spanne:
$7.77
$8.135
1-Wochen-Bereich:
$7.565
$8.39
52-Wochen-Spanne:
$5.01
$11.97
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.98 | 1.25B | 1.12B | 440.30M | -251.02M | 2.3805 |
VRTX
Vertex Pharmaceuticals Inc
|
433.56 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.84 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.14 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.59 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.86 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Traders Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX) - MarketBeat
Levels Update: Is Novavax Inc benefiting from interest rate changes2026 Sector Moves & Weekly Setup with ROI Potential - baoquankhu1.vn
Novavax, Inc. (NVAX) stock price, news, quote and history - Yahoo Finance UK
Behavioral Patterns of NVAX and Institutional Flows - Stock Traders Daily
Novavax Inc stock: Biotech innovator or fading COVID play? - AD HOC NEWS
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
Novavax (NASDAQ:NVAX) Shares Down 5.4%Should You Sell? - MarketBeat
NVAX Stock Price, Quote & Chart | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Novavax Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com
Novavax Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Novavax (XTER:NVV1) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook - Yahoo Finance
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - MarketBeat
Novavax names Robert Walker as R&D head By Investing.com - Investing.com South Africa
Novavax Stock Crosses 200-Day Moving Average - National Today
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Novavax Inc. stock underperforms Monday when compared to competitors - marketwatch.com
Novavax names new R&D chief as previous leader departs after less than two years - The Business Journals
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next - 24/7 Wall St.
Novavax, Inc. Announces Executive Changes - marketscreener.com
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development - citybiz
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Novavax names Robert Walker as R&D head - investing.com
After 30 years in vaccines, Robert Walker takes over Novavax R&D - Stock Titan
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Equity in earnings of Novavax, Inc. – BSESOF:NVV1 - TradingView
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Novavax (NVAX) Stock Trades Down, Here Is Why - Yahoo Finance
Vanguard (NVAX) amends 13G/A, reports 0 shares after Jan 12, 2026 realignment - Stock Titan
Novavax (XSWX:NVAX) PB Ratio : (As of Mar. 26, 2026) - GuruFocus
Novavax (NVAX) Declines Sharply Compared to Overall Market: Key Information for Investors - Bitget
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Novavax Inc stock faces renewed scrutiny amid biotech sector volatility and pipeline updates - AD HOC NEWS
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
NVAX SEC FilingsNovavax Inc 10-K, 10-Q, 8-K Forms - Stock Titan
(NVAX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Novavax Inc. stock rises Monday, still underperforms market - marketwatch.com
Novavax Q2 2025 Earnings Preview - MSN
Wall Street Recap: Can Novavax Inc stock outperform in a bear marketTrade Entry Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Q3 Earnings Estimate for Novavax Issued By Zacks Research - MarketBeat
2 Healthcare Stocks to Target This Week and 1 That Underwhelm - The Globe and Mail
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations - Yahoo Finance
Aug Selloffs: Is Novavax Inc benefiting from interest rate changesMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
NVAX stock rises overnight ahead of Q4 print with Pfizer tailwinds — analyst warns of 20% crash - MSN
Novavax (NVAX) Shares Drop 1.23%: Key Information to Note - Bitget
Novavax (NVAX) Stock Moves -1.23%: What You Should Know - Yahoo! Finance Canada
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 07 '26 |
Option Exercise |
0.00 |
12,223 |
0 |
136,503 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 03 '26 |
Option Exercise |
0.00 |
43,167 |
0 |
145,130 |
| Jacobs John C | President and CEO |
Mar 03 '26 |
Option Exercise |
0.00 |
150,167 |
0 |
264,130 |
| O'Hara Elaine | EVP, Chief Strategy Officer |
Mar 03 '26 |
Option Exercise |
0.00 |
56,334 |
0 |
157,071 |
| Casey Mark J | EVP, Chief Legal Officer |
Mar 03 '26 |
Option Exercise |
0.00 |
37,500 |
0 |
101,445 |
| Draghia-Akli Ruxandra | EVP, Research & Development |
Mar 03 '26 |
Option Exercise |
0.00 |
26,667 |
0 |
34,876 |
| Jacobs John C | President and CEO |
Mar 01 '26 |
Option Exercise |
0.00 |
83,333 |
0 |
264,130 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
58,666 |
0 |
130,299 |
| O'Hara Elaine | EVP, Chief Strategy Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
59,600 |
0 |
111,706 |
| Casey Mark J | EVP, Chief Legal Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
4,000 |
0 |
65,159 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):